Predictmedix (PMED.C) inks deal to install COVID-19 Mass Screening Tech

Get Safe Entry

On May 20, 2020 Predictmedix (PMED.C) cut a deal with Juiceworks Exhibits –  a company that “creates brand experiences” for leading companies across North America with operations both in Canada and the USA.

PMED’s business objective: deploy artificial intelligence (AI) to disrupt impairment testing and healthcare.

Three weeks ago, Predictmedix filed a Patent Application in the U.S. for its AI-driven rapid screening system for infectious diseases.

Last week, Predictmedix appointed Kapil Raval to be the Chairman of its Advisory Board. Kapil is currently a director at the $1.4 trillion Microsoft (MSFT.NASDAQ).

Continue reading the article here.

Other News Articles